STING1 and vascular disorder: Their derivatives also covalently modified the Cys88 and Cys91 residues of STING to inhibit its palmitoylation, thereby inhibiting the production of IFN-I in fibroblasts from patients with STING-associated vasculopathy in infancy [121].